Sherman Oaks, CA, United States of America

Charles Patrick Reynolds


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Charles Patrick Reynolds

Introduction

Charles Patrick Reynolds is an accomplished inventor based in Sherman Oaks, CA. He has made significant contributions to the field of oral pharmaceutical compositions, focusing on enhancing the bioavailability of active agents. With a total of 2 patents to his name, Reynolds continues to push the boundaries of innovation in his field.

Latest Patents

Reynolds' latest patents include "Oral compositions of fenretinide having increased bioavailability and methods of using the same." This invention provides an edible composition for the oral delivery of an active agent such as a retinide. The composition consists of a dry flowable powder that includes an active agent, a lipid matrix composition, and optionally a sweetener and flour. These compositions can be administered directly or mixed with food carriers for consumption. Another notable patent is "Oral pharmaceutical compositions and methods of using the same," which similarly focuses on the oral delivery of active agents like paclitaxel or retinide, utilizing a comparable composition structure.

Career Highlights

Reynolds is currently affiliated with Children's Hospital Los Angeles, where he applies his expertise in developing innovative oral compositions. His work is instrumental in improving patient care through enhanced drug delivery methods.

Collaborations

Throughout his career, Reynolds has collaborated with notable colleagues, including Barry J Maurer and David W Yesair. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Charles Patrick Reynolds exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to oral compositions are paving the way for improved therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…